Amgen to Gain Eye Disease Blockbuster Drug in $28B Horizon Therapeutics Buyout

In the biggest pharmaceutical purchase announced this year, Amgen has inked a $28 billion deal with Horizon Therapeutics, gaining access to one blockbuster eye drug and two others that are future revenue-drivers.
Source: Drug Industry Daily